Is HBsAg loss an ideal end-point of oral antiviral therapy in chronic hepatitis B patients?

Keunhee Kang, Ji H.oon Kim

Research output: Contribution to journalComment/debatepeer-review

Fingerprint Dive into the research topics of 'Is HBsAg loss an ideal end-point of oral antiviral therapy in chronic hepatitis B patients?'. Together they form a unique fingerprint.